Transcutaneous signal transmission system and methods

• US 4,441,210 A
• Filed: 09/18/1981
• Issued: 04/03/1984
• Est. Priority Date: 09/18/1981
• Status: Expired due to Term

• Current Assignee: Erwin S. Hochmair, Ingeborg J. Hochmair
• Original Assignee: Erwin S. Hochmair, Ingeborg J. Hochmair
• Inventors: Hochmair, Erwin S., Hochmair, Ingeborg J.
• Primary Examiner(s): Bookbinder, Marc E.
• Application Number:
  US06/303,590
• Time in Patent Office: 928 Days
• Field of Search: 455/41, 455/67, 179/82, 179/107 BC, 179/107 E, 128/1.5, 128/419 PG, 128/419 PT, 333/177, 333/180, 324/207, 324/208, 324/55, 334/61, 336/115, 336/129
• US Class Current: 455/41.1
• CPC Class Codes: A61F 11/04 Methods or devices for enabling ear patients to achieve auditory perception through physiological senses other than hearing sense, e.g. through the touch sense electronic stimulation of auditory nerves A61N1/36036
• CPC Class Codes: A61N 1/3787 from an external energy source
• CPC Class Codes: Y10S 128/903 Radio telemetry

Abstract

Greater positioning tolerance is permitted in inductively coupled transmitter and receiver tuned circuits by achieving critical coupling therebetween. Critical coupling at a predetermined distance is obtained by selecting the appropriate quality, Q, of the tuned circuit, whereby the quality of the transmitter tuned circuit is preferably three times larger than the quality of the receiver tuned circuit. In a transcutaneous signal transmission system the critical coupling is realized by adjusting the spacing of the coils of the tuned circuits whereby the output impedance of the transmitter decreases to one-half the output impedance with no coupling.

Claims

1. In a transcutaneous signal transmission system having an external transmitter and a living body-implanted receiver, a method for placing a first coupling coil of said transmitter with respect to a second coupling coil of said receiver to achieve critical coupling comprising the steps of driving said first coupling coil of said transmitter with an unsaturated current source, measuring the output voltage of said transmitter and adjusting the space between said first and second coupling coils whereby the output voltage of said transmitter decreases to one-half of the output voltage with no coupling.

2. The method as defined by claim 1 wherein said first coupling coil and said second coupling coil comprise respective parts of a first tuned circuit and a second tuned circuit, said first and second tuned circuits having qualities, Q, which are selected whereby critical coupling of said first and second coils is achieved at a spacing of sufficient width to bridge the skin barrier of a patient.

3. A method of enhancing the positioning tolerance of an external transmitter tuned circuit coupling coil with respect to a living body-implanted receiver tuned circuit coupling coil and achieving essentially critical coupling of said transmitter coupling coil and said receiver coupling coil wherein the transmitter tuned circuit and the implanted receiver tuned circuit having quality values greater than five with said transmitter tuned circuit having a quality on the order of at least 3 times that of said receiver tuned circuit, comprising the steps of:

driving said transmitter tuned circuit with an unsaturated current source, measuring an output voltage of said transmitter, and positioning said transmitter coupling coil with respect to said receiver coupling coil until the output voltage of said transmitter is on the order of one-half of the unloaded output voltage of said transmitter.

4. A transcutaneous signal transmission system in which auditory signals are transmitted from a transmitter means outside of a patient to a receiver means implanted in the patient characterized by a first tuned circuit of said transmitter means and a second tuned circuit of said receiver means being positioned to achieve essentially critical coupling with optimal displacement tolerance of said first and second tuned circuits.

5. A transcutaneous signal transmission system as defined by claim 4 wherein said first and second tuned circuits cooperatively function as a current driven band-pass filter.

6. A transcutaneous signal transmission system as defined by claim 4 or 5 wherein each of said tuned circuits has a quality factor greater than 5.

7. A transcutaneous signal transmission system as defined by claim 6 wherein the quality of said first tuned circuit is at least 3 times greater than the quality of said second tuned circuit.

8. A transcutaneous signal transmission system comprising:

transmitter means located externally of a living body including a first carrier signal generator, a modulation signal generator, a first modulator for modulating a carrier signal from said first carrier signal generator with a modulation signal and including a first non-saturating RF output transistor, and a first tuned circuit including a first inductor for receiving an amplified modulated carrier signal from said first output transistor,

receiver means implanted in said body and comprising a second tuned circuit including a second inductor and a detector, and

said first tuned circuit and said second tuned circuit cooperatively functioning as a band-pass filter with said first and second inductors being positioned to achieve essentially critical coupling with optimal displacement tolerance of said first and second tuned circuits.

9. A transcutaneous signal transmission system as defined by claim 8 wherein said transmitter means further includes a second carrier signal generator, a second modulator for modulating a carrier signal from said second carrier signal generator with a modulation signal and including a second non-saturating RF output transistor, a third tuned circuit including a third inductor for receiving an amplified modulated carrier signal from said second output transistor, phase splitting means coupling said modulation signal to said first and second modulators in phase opposition, said first and third tuned circuits being connected to be driven individually by said first and second modulators, respectively.

10. A transcutaneous signal transmission system as defined by claim 9 wherein said receiver means further includes a fourth tuned circuit positioned to be critically coupled with said third tuned circuit of said transmitter means and wherein said receiver means further includes a pair of oppositely poled diode rectifiers serially connected between said second and fourth tuned circuits and having a junction point, and a parallel resistance-capacitance load connected to said junction point.

11. In a transcutaneous signal transmission system having an external transmitter and an implanted receiver, a method for placing a first coupling coil of said transmitter with respect to a second coupling coil of said receiver to achieve critical coupling comprising the steps of driving said first coupling coil of said transmitter with an unsaturated current source, measuring output voltage of said transmitter, and moving said first coupling coil with respect to said second coupling coil until the output voltage of said transmitter decreases to one-half of the output voltage with no coupling of said first coupling coil and said second coupling coil.